Benzinga | Aug 16, 2021 09:31AM EDT

Moderna Announces Revised Supply Agreement With Canada For Up To 105M Doses OF Its COVID-19 Vaccine And Booster Vaccine Candidate, If Authorized, For Delivery Through 2024

For 2022 and 2023, agreement provides for 20 million doses each year with option for additional 15 million doses each year

For 2024, agreement provides option for up to 35 million additional doses

Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a revised supply agreement with the Government of Canada for up to 105 million doses of Moderna's COVID-19 vaccine and its booster vaccine candidate, if authorized, for delivery through 2024. The agreement provides for 20 million doses each year in 2022 and 2023, with an option for an additional 15 million doses each year. For 2024, the agreement provides an option for up to 35 million doses.

"We thank the Government of Canada for their support in this supply agreement for our mRNA COVID-19 vaccine and booster candidate, if approved," said St?phane Bancel, Moderna's Chief Executive Officer. "This agreement reflects the efforts of the Canadian government to address the ongoing pandemic and builds on our existing collaboration to protect Canadian citizens."